Use of proton pump inhibitors during pregnancy and breastfeeding
- PMID: 16893146
- PMCID: PMC1781096
Use of proton pump inhibitors during pregnancy and breastfeeding
Abstract
Question: A 36-year-old pregnant patient has symptoms of peptic disease. Treatment with diet and lifestyle modifications and also antacids has given her little relief. If she were not pregnant, I would prescribe a proton pump inhibitor (PPI) for her. She is now 4 weeks pregnant, and I need to determine whether PPIs are safe during pregnancy.
Answer: Data currently available suggest that omeprazole is not teratogenic in humans. While information on other PPIs is limited, a systematic review of the evidence suggests that they are also not teratogenic.
QUESTION: Une patiente enceinte âgée de 36 ans présente des symptômes de maladie peptique. Le traitement par des changements dans l’alimentation et le mode de vie ainsi que l’administration d’antiacides l’ont très peu soulagée. Si elle n’était pas enceinte, je lui prescrirais l’inhibiteur de pompe à protons (IPP). Elle en est à quatre semaines de gestation et je dois déterminer si les IPP sont sans danger durant la grossesse.
RÉPONSE: Les données actuellement accessibles indiquent que l’oméprazole n’est pas tératogène chez l’humain. Même si les renseignements sur d’autres IPP sont limités, une synthèse critique des données scientifiques fait valoir qu’ils ne sont pas tératogènes non plus.
Similar articles
-
The clinical and economic impact of competing management strategies for gastro-oesophageal reflux disease.Aliment Pharmacol Ther. 2002 Feb;16(2):261-73. doi: 10.1046/j.1365-2036.2002.01167.x. Aliment Pharmacol Ther. 2002. PMID: 11860409
-
Medical treatments for the maintenance therapy of reflux oesophagitis and endoscopic negative reflux disease.Cochrane Database Syst Rev. 2005 Apr 18;(2):CD003245. doi: 10.1002/14651858.CD003245.pub2. Cochrane Database Syst Rev. 2005. Update in: Cochrane Database Syst Rev. 2010 Feb 17;(2):CD003245. doi: 10.1002/14651858.CD003245.pub3. PMID: 15846653 Updated.
-
Interventions for preventing upper gastrointestinal bleeding in people admitted to intensive care units.Cochrane Database Syst Rev. 2018 Jun 4;6(6):CD008687. doi: 10.1002/14651858.CD008687.pub2. Cochrane Database Syst Rev. 2018. PMID: 29862492 Free PMC article.
-
A comparison of the cost-effectiveness of five strategies for the prevention of non-steroidal anti-inflammatory drug-induced gastrointestinal toxicity: a systematic review with economic modelling.Health Technol Assess. 2006 Oct;10(38):iii-iv, xi-xiii, 1-183. doi: 10.3310/hta10380. Health Technol Assess. 2006. PMID: 17018227
-
Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.Cochrane Database Syst Rev. 2001;(4):CD002095. doi: 10.1002/14651858.CD002095. Cochrane Database Syst Rev. 2001. Update in: Cochrane Database Syst Rev. 2004 Oct 18;(4):CD002095. doi: 10.1002/14651858.CD002095.pub2. PMID: 11687139 Updated.
Cited by
-
Treating common ear problems in pregnancy: what is safe?Eur Arch Otorhinolaryngol. 2008 Feb;265(2):139-45. doi: 10.1007/s00405-007-0534-3. Epub 2007 Nov 23. Eur Arch Otorhinolaryngol. 2008. PMID: 18034353 Review.
-
Diagnosis and treatment of hyperemesis gravidarum.CMAJ. 2024 Apr 14;196(14):E477-E485. doi: 10.1503/cmaj.221502. CMAJ. 2024. PMID: 38621783 Free PMC article. Review. No abstract available.
-
Treatment of heartburn and acid reflux associated with nausea and vomiting during pregnancy.Can Fam Physician. 2010 Feb;56(2):143-4. Can Fam Physician. 2010. PMID: 20154244 Free PMC article.
-
Treating common problems of the nose and throat in pregnancy: what is safe?Eur Arch Otorhinolaryngol. 2008 May;265(5):499-508. doi: 10.1007/s00405-008-0601-4. Epub 2008 Feb 12. Eur Arch Otorhinolaryngol. 2008. PMID: 18265995 Review.
References
-
- Raghunath AS, O’Morain C, McLoughlin RC. Review article: the long-term use of proton-pump inhibitors. Aliment Pharmacol Ther. 2005;22(Suppl 1):55–63. - PubMed
-
- Richter JE. Gastroesophageal reflux disease during pregnancy. Gastroenterol Clin North Am. 2003;32:235–261. - PubMed
-
- Lalkin A, Loebstein R, Addis A, Ramezani-Namin F, Mastroiacovo P, Mazzone T, et al. The safety of omeprazole during pregnancy: a multicenter prospective controlled study. Am J Obstet Gynecol. 1998;179:727–730. - PubMed
-
- Nikfar S, Abdollahi M, Moretti ME, Magee LA, Koren G. Use of proton pump inhibitors during pregnancy and rates of major malformations: a meta-analysis. Dig Dis Sci. 2002;47:1526–1529. - PubMed
-
- Kallen BA. Use of omeprazole during pregnancy—no hazard demonstrated in 955 infants exposed during pregnancy. Eur J Obstet Gynecol Reprod Biol. 2001;96:63–68. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
